Methodology Issues in a Tailored Light Treatment for Persons With Dementia - Aim 2

ID#: NCT05837819

Age: 65 years - 66+

Gender: All

Healthy Subjects: No

Study Phase: N/A

Recruitment Status: Recruiting

Start Date: February 14, 2023

End Date: December 01, 2025

Contact Information:
Barbara Plitnick
518-242-4603
Summary: Aim 2 will investigate the effect of 3 different light exposure lengths on sleep, mood and agitation in persons with Alzheimer's disease. Participants will be randomly assigned to one of three conditions of light exposure: 1) 2-h morning light exposure; 2) 4-h morning light exposure; and 3) all day light exposure.
Eligibility:

Inclusion Criteria:

- Diagnosis of Alzheimer's disease or related dementia with a Montreal Cognitive Assessment score <25

- Sleep disturbance with a Pittsburgh Sleep Quality Index score ≥5

Exclusion Criteria:

- Extensive brain vascular disease, traumatic brain injury, multiple sclerosis, Parkinson's Disease

- Obstructing cataracts

- Severe macular degeneration

- Use of sleep medication

- Use of oral melatonin

- untreated moderate to severe sleep apnea

- Severe restless leg syndrome

- Blindness
Find a Clinical Trial Find Cancer Clinical Trials